Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations France

Research

Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations
Count Share
1 0.02

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.02

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.20 0.56 0.00 0.00 0.07

Compare Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations with other institutions

Collaboration

Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 22.58% Domestic
  • 77.42% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations by Share (11 total)

  1. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.09)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.07
  2. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Da Volterra (0.09)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Da Volterra0.07
  3. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and CHU Limoges (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    CHU Limoges0.02
  4. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Centre Hospitalier Départemental Vendée (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Centre Hospitalier Départemental Vendée0.02
  5. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Centre Hospitalier Régional Universitaire de TOURS (CHRU de Tours) (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Centre Hospitalier Régional Universitaire de TOURS (CHRU de Tours)0.02
  6. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Centre Hospitalier de Cornouaille (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Centre Hospitalier de Cornouaille0.02
  7. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Infection, Antimicrobials, Modelling, Evolution (IAME) (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Infection, Antimicrobials, Modelling, Evolution (IAME)0.02
  8. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and National Institute for Health and Medical Research (INSERM) (0.03)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    National Institute for Health and Medical Research (INSERM)0.01
  9. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and University of Limoges (ULIM) (0.03)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    University of Limoges (ULIM)0.01
  10. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and University of Paris (0.02)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    University of Paris0.01

Top 10 international collaborators with Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations by Share (42 total)

  1. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and University of Antwerp (UA) (0.12)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    University of Antwerp (UA)0.10
  2. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Utrecht University (UU) (0.09)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Utrecht University (UU)0.07
  3. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Catalan Health Institute (ICS) (0.07)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Catalan Health Institute (ICS)0.05
  4. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and National and Kapodistrian University of Athens (UOA) (0.07)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    National and Kapodistrian University of Athens (UOA)0.05
  5. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and University of Cologne (UoC) (0.06)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    University of Cologne (UoC)0.04
  6. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Dr. Victor Babeș Timișoara Infectious Diseases and Pneumophysiology Clinical Hospital (0.05)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Dr. Victor Babeș Timișoara Infectious Diseases and Pneumophysiology Clinical Hospital0.04
  7. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and University General Hospital of Heraklion (PAGNI) (0.05)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    University General Hospital of Heraklion (PAGNI)0.04
  8. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and Belgian Nuclear Research Centre (SCK•CEN) (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    Belgian Nuclear Research Centre (SCK•CEN)0.03
  9. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and DZIF Partner Site Bonn-Cologne (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    DZIF Partner Site Bonn-Cologne0.02
  10. Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations and RWTH Aachen University (RWTH Aachen) (0.04)
    Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations0.02
    RWTH Aachen University (RWTH Aachen)0.02

Relationships

Partner Institutions

Anti-Infective Agents: Supports Resistance and Molecular Therapeutic Innovations is a research collaboration whose article contributions are accrued to its participating partner institutions below.